Krege S. (Ed.) Diagnosis and Management of Testicular Cancer: The European Point of View

Springer International Publishing, 2015. — 135 p. — ISBN: 978-3-319-17466-2, 978-3-319-17467-9.Presents the European perspective on the diagnosis and management of testicular cancer
Summarizes the most recent recommendations from the European Germ Cell Cancer Consensus Group
Discusses current areas of controversy, with presentation of new findings that might alter treatment recommendationsThis book presents the views of leading European experts on the diagnosis and management of testicular cancer, with coverage of current hot topics in the field. It opens by providing an overview of the recommendations in the most recent consensus paper from the European Germ Cell Cancer Consensus Group, which is based on interdisciplinary cooperation among urologists, medical oncologists, radio-oncologists, pathologists, and basic scientists. The remainder of the book focuses on areas of controversy in the diagnosis, treatment, and follow-up of testicular cancer. In each case the evidence base is discussed and results from the most recent studies are reviewed, drawing attention to new findings that might alter treatment recommendations. The treatment-related chapters cover a broad range of issues, including the best approach in patients with poor-prognosis and recurrent disease and those with long-term toxicities. Relevant aspects of survivorship care are also addressed. The book will help clinicians and practitioners to achieve the goals of minimizing therapy and its side-effects without reducing efficacy in low stage disease, improving the cure rate in advanced disease, and enhancing follow-up and long-term survivorship.Latest Recommendations of the European Germ Cell Cancer Group on Diagnosis and Treatment of Germ Cell Cancer
Is There Still an Indication for Radiotherapy in Seminoma Clinical Stages I–IIA/B?
How Should We Treat Clinical Stage I (CSI) Nonseminoma
Is There Still an Indication for Primary RPLND in Clinical Stage I Non-seminoma?
Metastatic Germ Cell Cancer: The Intermediate-Prognosis Risk Category
Poor-Prognosis Germ Cell Tumours
How Should Patients with Recurrent Disease Be Treated Actually?
Prognostic Factors at Initial Presentation and in Recurrent Disease
Postchemotherapy Retroperitoneal Lymph Node Dissection
What Are the Recent Recommendations for Follow-Up in Testicular Cancer?
What Are the Long-Term Toxicities to Be Controlled and Treated?
Consequences of the Disease and Its Treatment Concerning Sexuality and Fertility